NSD2 and metabolic dysfunction-associated steatohepatitis: NSD2 directly regulates the transcriptional activation of ERN1 through the demethylation of histone H3 at lysine 36 (H3K36me2), thereby activating the ERN1–JNK axis to exacerbate intestinal barrier impairment and subsequently promote NASH progression.